Social Disadvantage and COVID-19 Outcomes Among Dialysis Patients in the Provence-Alpes-Côte d'Azur Region of France: A Study Beyond Healthcare Access - Scorecard - MDSpire

Social Disadvantage and COVID-19 Outcomes Among Dialysis Patients in the Provence-Alpes-Côte d'Azur Region of France: A Study Beyond Healthcare Access

  • By

  • Franck Mazoué

  • Sébastien Cortaredona

  • Adeline Crémades

  • Ghizlane Izaaryene

  • Bénédicte Devictor

  • Philippe Brunet

  • Stéphanie Gentile

  • February 10, 2026

  • 0 min

Share

Clinical Scorecard: Social Disadvantage and COVID-19 Outcomes Among Dialysis Patients in the Provence-Alpes-Côte d'Azur Region of France: A Study Beyond Healthcare Access

At a Glance

CategoryDetail
ConditionCOVID-19 outcomes in dialysis patients
Key MechanismsSocioeconomic deprivation influencing infection risk and severity despite equitable healthcare access
Target PopulationAdult dialysis patients in the Provence-Alpes-Côte d'Azur region
Care SettingDialysis units within the national health insurance framework

Key Highlights

  • COVID-19 outcomes affected by socioeconomic factors beyond healthcare access
  • Dialysis patients have a high prevalence of comorbidities, increasing vulnerability
  • Study conducted on 5470 dialysis patients in the PACA region during the first year of the pandemic

Guideline-Based Recommendations

Diagnosis

  • Monitor COVID-19 incidence and outcomes in dialysis patients

Management

  • Ensure continuity of care for dialysis patients during pandemics

Monitoring & Follow-up

  • Utilize the REIN registry for ongoing surveillance of dialysis patients

Risks

  • Identify and address socioeconomic factors contributing to poor outcomes

Patient & Prescribing Data

Dialysis patients over 18 years old in the PACA region

Regular dialysis treatment is essential and maintained during health crises

Clinical Best Practices

  • Implement standardized clinical protocols for dialysis care
  • Ensure equitable access to dialysis treatment regardless of socioeconomic status
  • Monitor comorbidities and their impact on COVID-19 outcomes

References

Original Source(s)

Social Disadvantage and COVID-19 Outcomes Among Dialysis Patients in the Provence-Alpes-Côte d'Azur Region of France: A Study Beyond Healthcare Access

  • by Franck Mazoué, Sébastien Cortaredona, Adeline Crémades, Ghizlane Izaaryene, Bénédicte Devictor, Philippe Brunet, Stéphanie Gentile

  • February 10, 2026

Related Content

Editorial: Lipid influence on lung immune-structural cell crosstalk: implications for respiratory health

JinHuangJieDu (JHJD) formula attenuates SARS-CoV-2 infection by interrupting RBD-ACE2 binding and HIF-1α-dependent inflammation

Raman Spectroscopy Moves to the Front Line of Pandemic Preparedness

Comprehensive review highlights label-free viral detection – and the hurdles to real-world deployment

  • May 7, 2026

  • 2 min